$72.77
N/A
Last update: Nov 6, 4:00 PM
Corcept Therapeutics Inc
CORTNASDAQ
The average analyst price target for Corcept Therapeutics is $128.50, 76.6% above the current price. Of 6 analysts, 5 rate it Buy and 1 Sell. Targets range from $50 to $173. The latest change came on Nov 4, 2026, when Piper Sandler raised its price target on Corcept Therapeutics from $165 to $173 and kept an Overweight rating.
Price Target Range — 13 Quarters
Analyst Consensus — 6 Analysts
Rating Trend — Last 9 Months
